ARK Genomic Revolution ETF vs AngloGold Ashanti Limited — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while AngloGold Ashanti Limited trades at $101.15 (market cap $49.28B). The key difference: AngloGold Ashanti Limited pays a 4.64% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, AngloGold Ashanti Limited nearer its low. Which is the better fit depends on your goals.
| ARKG | AU | |
|---|---|---|
Sector | Sector/Thematic | Basic Materials |
52-Week High | $44.55 | $128.26 |
52-Week Low | $24.02 | $52.15 |
Market Cap | — | $49.28B |
Enterprise Value | — | $48.29B |
Dividend Yield | — | 4.64% |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
Read more on AU →